Does vitamin D deficiency increase the severity of COVID-19?
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
The severity of coronavirus 2019 infection (COVID-19) is determined by the presence of pneumonia, severe acute respiratory distress syndrome (SARS-CoV-2), myocarditis, microvascular thrombosis and/or cytokine storms, all of which involve underlying inflammation. A principal defence against uncontrolled inflammation, and against viral infection in general, is provided by T regulatory lymphocytes (Tregs). Treg levels have been reported to be low in many COVID-19 patients and can be increased by vitamin D supplementation. Low vitamin D levels have been associated with an increase in inflammatory cytokines and a significantly increased risk of pneumonia and viral upper respiratory tract infections. Vitamin D deficiency is associated with an increase in thrombotic episodes, which are frequently observed in COVID-19. Vitamin D deficiency has been found to occur more frequently in patients with obesity and diabetes. These conditions are reported to carry a higher mortality in COVID-19. If vitamin D does in fact reduce the severity of COVID-19 in regard to pneumonia/ARDS, inflammation, inflammatory cytokines and thrombosis, it is our opinion that supplements would offer a relatively easy option to decrease the impact of the pandemic.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical and immunological features of severe and moderate coronavirus disease 2019
Chen, G., Wu, D., Guo, W., Cao, Y., Huang, D., Wang, H., Wang, T., Zhang, X., Chen, H., Yu, H., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci137244 · Cited by 4,750
Martineau, A. R., Jolliffe, D. A., Hooper, R. L., Greenberg, L., Aloia, J. F., Bergman, P., Dubnov-Raz, G., Esposito, S., Ganmaa, D., Ginde, A. A., et al. (2017) · BMJ · doi:10.1136/bmj.i6583 · Cited by 2,040
Giannis, D., Ziogas, I. A., & Gianni, P. (2020) · Journal of Clinical Virology · doi:10.1016/j.jcv.2020.104362 · Cited by 893
Lips, P., Cashman, K. D., Lamberg-Allardt, C., Bischoff-Ferrari, H. A., Obermayer-Pietsch, B., Bianchi, M. L., Stepan, J., El-Hajj Fuleihan, G., & Bouillon, R. (2019) · European Journal of Endocrinology · doi:10.1530/eje-18-0736 · Cited by 662
Ginde (2019) · doi:10.1056/nejmoa1911124 · Cited by 286
Peterson, C. A., & Heffernan, M. E. (2008) · Journal of Inflammation · doi:10.1186/1476-9255-5-10 · Cited by 249
Fisher, S. A., Rahimzadeh, M., Brierley, C., Gration, B., Doree, C., Kimber, C. E., Plaza Cajide, A., Lamikanra, A. A., & Roberts, D. J. (2019) · PLOS ONE · doi:10.1371/journal.pone.0222313 · Cited by 162
Mohammad, S., Mishra, A., & Ashraf, M. Z. (2019) · Biomolecules · doi:10.3390/biom9110649 · Cited by 147
Science, M. E., Maguire, J. L., Russell, M. L., Smieja, M., Walter, S. D., & Loeb, M. B. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit289 · Cited by 146
Melzer, S., Zachariae, S., Bocsi, J., Engel, C., Löffler, M., & Tárnok, A. (2015) · Cytometry Part B Clinical Cytometry · doi:10.1002/cyto.b.21234 · Cited by 101
Prietl, B., Treiber, G. M., Mader, J. K., Höller, E., Wolf, M., Pilz, S., Graninger, W. B., Obermayer-Pietsch, B. M., & Pieber, T. R. (2013) · European Journal of Nutrition · doi:10.1007/s00394-013-0579-6 · Cited by 84
Mohammed, H. A., Mirshafiey, A., Vahedi, H., Hemmasi, G., Khameneh, A., Parastouei, K., & Saboor-Yaraghi, A. A. (2017) · Scandinavian Journal of Immunology · doi:10.1111/sji.12547 · Cited by 67
Immune Biomarkers Predictive of Respiratory Viral Infection in Elderly Nursing Home Residents
Johnstone, J., Parsons, R., Botelho, F., Millar, J., McNeil, S., Fulop, T., McElhaney, J., Andrew, M. K., Walter, S. D., Devereaux, P. J., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0108481 · Cited by 55
Link between community-acquired pneumonia and vitamin D levels in older patients
Lu, D.-X., Zhang, J., Ma, C., Yue, Y., Zou, Z., Yu, C., & Yin, F. (2017) · Zeitschrift für Gerontologie und Geriatrie · doi:10.1007/s00391-017-1237-z · Cited by 40
Memory regulatory T cells home to the lung and control influenza A virus infection
Lu, C., Zanker, D. J., Lock, P., Jiang, X., Deng, J., Duan, M., Liu, C., Faou, P., Hickey, M. J., & Chen, W. (2019) · Immunology and Cell Biology · doi:10.1111/imcb.12271 · Cited by 30
High-Dose Vitamin D3 for Critically Ill Vitamin D-Deficient Patients. Reply.
Ginde, A. A., & Talmor, D. S. (2020) · PubMed · doi:10.1056/nejmc2000993 · Cited by 12
Cited by
Merzon, E., Tworowski, D., Gorohovski, A., Vinker, S., Golan Cohen, A., Green, I., & Frenkel‐Morgenstern, M. (2020) · The FEBS Journal · doi:10.1111/febs.15495 · Cited by 432
Sarcopenia during COVID-19 lockdown restrictions: long-term health effects of short-term muscle loss
Kirwan, R., McCullough, D., Butler, T., Perez de Heredia, F., Davies, I. G., & Stewart, C. (2020) · GeroScience · doi:10.1007/s11357-020-00272-3 · Cited by 324
Sinopoli, A., Sciurti, A., Isonne, C., Santoro, M. M., & Baccolini, V. (2024) · Nutrients · doi:10.3390/nu16091345 · Cited by 40
“Clinical studies show that vitamin D deficiency is associated with a higher risk of respiratory infections, including COVID-19 [8]; some authors have reported the positive effect of vitamin A supplementation on the risk of severe diseases via an immunomodulatory and anti-inflammatory effect,…”
Background
Metadata
- Authors
- Weir, E. K., Thenappan, T., Bhargava, M., & Chen, Y.
- Venue
- Clinical Medicine
- Publisher
- Elsevier BV
- Published
- 2020-07
- Volume
- 20
- Issue
- 4
- Pages
- e107-e108
- ISSN
- 1470-2118 (ISSN-L)
- OpenAlex
- W3034118652
- Cited by
- 265
- References
- 16
- FWCI
- 30.09
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.